Storen Legacy Partners LLC bought a new position in Marsh & McLennan Companies, Inc. (NYSE:MRSH – Free Report) during the 4th quarter, Holdings Channel.com reports. The institutional investor bought 8,499 shares of the financial services provider’s stock, valued at approximately $1,577,000. Marsh & McLennan Companies comprises about 0.5% of Storen Legacy Partners LLC’s holdings, making the stock its 19th largest holding.
A number of other large investors also recently bought and sold shares of MRSH. State Street Corp purchased a new stake in shares of Marsh & McLennan Companies during the 4th quarter valued at $4,057,682,000. Capital International Investors purchased a new position in shares of Marsh & McLennan Companies in the 4th quarter worth $3,482,557,000. Capital World Investors acquired a new position in Marsh & McLennan Companies in the fourth quarter valued at $3,140,284,000. Wellington Management Group LLP purchased a new stake in Marsh & McLennan Companies during the fourth quarter valued at about $2,967,927,000. Finally, Price T Rowe Associates Inc. MD acquired a new stake in Marsh & McLennan Companies during the fourth quarter worth about $1,710,101,000. Hedge funds and other institutional investors own 87.99% of the company’s stock.
Insider Activity at Marsh & McLennan Companies
In related news, CEO John Q. Doyle sold 16,656 shares of Marsh & McLennan Companies stock in a transaction on Tuesday, June 2nd. The shares were sold at an average price of $161.71, for a total value of $2,693,441.76. Following the completion of the sale, the chief executive officer owned 116,811 shares in the company, valued at approximately $18,889,506.81. The trade was a 12.48% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Company insiders own 0.38% of the company’s stock.
Marsh & McLennan Companies Stock Performance
Marsh & McLennan Companies (NYSE:MRSH – Get Free Report) last posted its earnings results on Thursday, April 16th. The financial services provider reported $3.29 EPS for the quarter, topping analysts’ consensus estimates of $3.21 by $0.08. Marsh & McLennan Companies had a net margin of 14.26% and a return on equity of 31.87%. The business had revenue of $7.30 billion for the quarter. Marsh & McLennan Companies’s quarterly revenue was up 7.6% compared to the same quarter last year. As a group, sell-side analysts forecast that Marsh & McLennan Companies, Inc. will post 10.38 EPS for the current fiscal year.
Analyst Ratings Changes
A number of analysts have recently issued reports on MRSH shares. UBS Group decreased their target price on Marsh & McLennan Companies from $230.00 to $203.00 and set a “buy” rating for the company in a report on Tuesday, June 9th. Barclays reduced their price target on shares of Marsh & McLennan Companies from $209.00 to $206.00 and set an “overweight” rating on the stock in a research report on Wednesday, April 8th. Piper Sandler dropped their price objective on shares of Marsh & McLennan Companies from $190.00 to $182.00 and set a “neutral” rating for the company in a research report on Tuesday, May 26th. JPMorgan Chase & Co. reduced their target price on shares of Marsh & McLennan Companies from $226.00 to $206.00 and set an “overweight” rating on the stock in a report on Thursday, April 9th. Finally, Bank of America decreased their price target on shares of Marsh & McLennan Companies from $181.00 to $174.00 and set an “underperform” rating for the company in a research report on Tuesday, April 14th. One analyst has rated the stock with a Strong Buy rating, six have given a Buy rating, ten have issued a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat, the company currently has a consensus rating of “Hold” and a consensus target price of $200.19.
Check Out Our Latest Report on Marsh & McLennan Companies
Marsh & McLennan Companies Profile
Marsh & McLennan Companies (NYSE: MMC) is a global professional services firm headquartered in New York City that provides advice and solutions in the areas of risk, strategy and people. Founded in 1905, the company has grown into a diversified group of businesses focused on insurance brokerage and risk management, reinsurance, human capital and investment consulting, and management consulting. Its long history and scale position it as a prominent adviser to corporations, governments and other institutions seeking to manage risk and optimize human and financial capital.
The firm operates through several well-known subsidiaries and business units that specialize in distinct services.
Read More
- Five stocks we like better than Marsh & McLennan Companies
- Aehr Spikes on New Order, But Has Stock Gotten Ahead of Itself?
- Rackspace’s AI Land Grab: Plugging Into the Next Compute Boom
- Satellogic Is Tiny But Its Revenue Growth Is Hard to Ignore
- Why Kroger’s Pullback Could Be a Gift for Patient Investors
Want to see what other hedge funds are holding MRSH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Marsh & McLennan Companies, Inc. (NYSE:MRSH – Free Report).
Receive News & Ratings for Marsh & McLennan Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Marsh & McLennan Companies and related companies with MarketBeat.com's FREE daily email newsletter.
